Vertaile menetelmiä
Tarkastele valitsemiasi menetelmiä rinnakkain; eroavat rivit korostetaan.
| Bayesiläinen Kaplan-Meier -analyysi× | Kaplan-Meier -analyysi× | |
|---|---|---|
| Tieteenala | Epidemiologia | Epidemiologia |
| Menetelmäperhe | Process / pipeline | Process / pipeline |
| Syntyvuosi≠ | 1976 | 1958 |
| Kehittäjä≠ | Susarla & Van Ryzin (Bayesian nonparametric survival estimation) | Edward L. Kaplan and Paul Meier |
| Tyyppi≠ | Bayesian nonparametric survival analysis | Nonparametric survival estimator |
| Alkuperäislähde≠ | Susarla, V., & Van Ryzin, J. (1976). Nonparametric Bayesian estimation of survival curves from incomplete observations. Journal of the American Statistical Association, 71(356), 897–902. DOI ↗ | Kaplan, E. L., & Meier, P. (1958). Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53(282), 457–481. DOI ↗ |
| Rinnakkaisnimet | Bayesian survival curve estimation, Bayesian nonparametric survival analysis, Dirichlet process Kaplan-Meier, BKM | KM analysis, KM estimator, product-limit estimator, Kaplan-Meier curve |
| Liittyvät≠ | 4 | 5 |
| Tiivistelmä≠ | Bayesian Kaplan-Meier analysis extends the classical Kaplan-Meier estimator by placing a prior distribution over the survival function and updating it with observed time-to-event data to obtain a full posterior distribution for the survival curve. This approach, rooted in Susarla and Van Ryzin's 1976 Dirichlet-process framework, yields credible intervals rather than confidence intervals and enables coherent incorporation of prior clinical knowledge, making it particularly valuable in small-sample or early-phase clinical settings. | Kaplan-Meier (KM) analysis is a nonparametric method for estimating the survival function from time-to-event data. Introduced by Kaplan and Meier in 1958, it produces the classic step-function survival curve that shows the probability of surviving beyond each observed event time, correctly accounting for censored observations — participants who left the study or had not yet experienced the event by the end of follow-up. It is one of the most widely used techniques in clinical and epidemiological research. |
| ScholarGateAineisto ↗ |
|
|